Published in Rheum Dis Clin North Am on February 01, 2018
Induction of intestinal Th17 cells by segmented filamentous bacteria. Cell (2009) 20.29
Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N Engl J Med (2001) 18.25
Induction of colonic regulatory T cells by indigenous Clostridium species. Science (2010) 16.71
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum (2008) 13.08
Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet (2010) 9.90
Gut-residing segmented filamentous bacteria drive autoimmune arthritis via T helper 17 cells. Immunity (2010) 8.90
Granulomatous infectious diseases associated with tumor necrosis factor antagonists. Clin Infect Dis (2004) 6.45
IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. J Immunol (1998) 5.79
Expansion of intestinal Prevotella copri correlates with enhanced susceptibility to arthritis. Elife (2013) 5.49
Tuberculosis of the gastrointestinal tract and peritoneum. Am J Gastroenterol (1993) 4.76
Peripheral vascular obstruction in rheumatoid arthritis and its relationship to other vascular lesions. Ann Rheum Dis (1957) 4.36
Gastrointestinal cytomegalovirus disease. Ann Intern Med (1993) 4.35
Extrapulmonary tuberculosis in the United States. Am J Epidemiol (1979) 3.53
Twin concordance rates for rheumatoid arthritis: results from a nationwide study. Br J Rheumatol (1993) 3.33
Coeliac disease--associated disorders and survival. Gut (1994) 3.13
The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med (2015) 3.01
Fecal microbiota in early rheumatoid arthritis. J Rheumatol (2008) 2.94
Systemic rheumatoid vasculitis: a clinical and laboratory study of 50 cases. Medicine (Baltimore) (1981) 2.84
Stimulation of TLR2 and TLR4 differentially skews the balance of T cells in a mouse model of arthritis. J Clin Invest (2008) 2.82
Mycobacterial and other serious infections in patients receiving anti-tumor necrosis factor and other newly approved biologic therapies: case finding through the Emerging Infections Network. Clin Infect Dis (2008) 2.69
Intestinal tuberculosis: return of an old disease. Am J Gastroenterol (1998) 2.67
Anti-tumor necrosis factor-alpha therapy-induced vasculitis: case series. J Rheumatol (2003) 2.67
Gastrointestinal histoplasmosis. Am J Gastroenterol (2005) 2.43
Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology (1990) 2.32
Life-threatening histoplasmosis complicating immunotherapy with tumor necrosis factor alpha antagonists infliximab and etanercept. Arthritis Rheum (2002) 2.12
A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am J Med (1969) 2.11
Presentation and outcome of gastrointestinal involvement in systemic necrotizing vasculitides: analysis of 62 patients with polyarteritis nodosa, microscopic polyangiitis, Wegener granulomatosis, Churg-Strauss syndrome, or rheumatoid arthritis-associated vasculitis. Medicine (Baltimore) (2005) 2.03
The lifetime risk of adult-onset rheumatoid arthritis and other inflammatory autoimmune rheumatic diseases. Arthritis Rheum (2011) 1.91
Relative importance of genetic effects in rheumatoid arthritis: historical cohort study of Danish nationwide twin population. BMJ (2002) 1.89
Nontuberculous mycobacteria infections and anti-tumor necrosis factor-alpha therapy. Emerg Infect Dis (2009) 1.81
Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern california-managed care organization. Am J Gastroenterol (2007) 1.78
IL-17 promotes bone erosion in murine collagen-induced arthritis through loss of the receptor activator of NF-kappa B ligand/osteoprotegerin balance. J Immunol (2003) 1.78
Systemic histoplasmosis: a 15-year retrospective institutional review of 111 patients. Medicine (Baltimore) (2007) 1.75
Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis. Arthritis Res Ther (2015) 1.61
Drug-specific risk of non-tuberculosis opportunistic infections in patients receiving anti-TNF therapy reported to the 3-year prospective French RATIO registry. Ann Rheum Dis (2010) 1.59
Features of Sjögren's syndrome in patients with primary biliary cirrhosis. J Intern Med (1991) 1.58
Etanercept can induce resolution of renal deterioration in patients with amyloid A amyloidosis secondary to rheumatoid arthritis. Clin Rheumatol (2010) 1.53
Vasculitis associated with rheumatoid arthritis: a case-control study. Rheumatology (Oxford) (2014) 1.49
Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology (2006) 1.45
Vasculitides induced by TNFalpha antagonists: a study in 39 patients in France. Joint Bone Spine (2006) 1.41
Cytomegalovirus colitis in the immunocompetent host: an overview. Scand J Infect Dis (1998) 1.39
Upper gastrointestinal disease in rheumatoid arthritis. Am J Dig Dis (1974) 1.38
Rheumatoid arthritis in Spain: occurrence of extra-articular manifestations and estimates of disease severity. Ann Rheum Dis (2003) 1.36
Genetics of rheumatoid arthritis - a comprehensive review. Clin Rev Allergy Immunol (2013) 1.31
Human rheumatoid arthritis tissue production of IL-17A drives matrix and cartilage degradation: synergy with tumour necrosis factor-alpha, Oncostatin M and response to biologic therapies. Arthritis Res Ther (2009) 1.28
Autonomic neuropathy in rheumatoid arthritis. Br Med J (1979) 1.28
Changing paradigms in Whipple's disease and infection with Tropheryma whipplei. Eur J Clin Microbiol Infect Dis (2011) 1.28
Rheumatoid vasculitis: becoming extinct? Rheumatology (Oxford) (2004) 1.25
Increased risk of coccidioidomycosis in patients treated with tumor necrosis factor alpha antagonists. Arthritis Rheum (2004) 1.25
Tumor necrosis factor blockade and the risk of viral infection. Nat Rev Rheumatol (2010) 1.24
Are individuals with an autoimmune disease at higher risk of a second autoimmune disorder? Am J Epidemiol (2009) 1.23
Factors associated with the development of vasculitis in rheumatoid arthritis: results of a case-control study. Ann Rheum Dis (1996) 1.23
Interleukin-22 promotes osteoclastogenesis in rheumatoid arthritis through induction of RANKL in human synovial fibroblasts. Arthritis Rheum (2011) 1.21
Anti-tumor necrosis factor alpha therapy in fifteen patients with AA amyloidosis secondary to inflammatory arthritides: a followup report of tolerability and efficacy. Arthritis Rheum (2003) 1.21
Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists. Am J Med (2005) 1.20
Sjögren's syndrome in patients with primary biliary cirrhosis. Hepatology (1990) 1.19
Recognition, diagnosis, and treatment of histoplasmosis complicating tumor necrosis factor blocker therapy. Clin Infect Dis (2010) 1.18
Cytomegalovirus infection of the human gastrointestinal tract. J Gastroenterol Hepatol (1999) 1.17
Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis (2008) 1.13
Spontaneous hepatic rupture in rheumatoid arthritis. Arch Intern Med (1981) 1.12
The liver is a common non-exocrine target in primary Sjögren's syndrome: a retrospective review. BMC Gastroenterol (2002) 1.10
Liver involvement in primary Sjögren's syndrome. Br J Rheumatol (1994) 1.09
Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis. Ann Rheum Dis (1999) 1.09
Celiac disease and markers of celiac disease latency in patients with primary Sjögren's syndrome. Am J Gastroenterol (1999) 1.09
Cytomegalovirus infection with acute erosive esophagitis. Am J Med (1984) 1.05
Sicca symptoms and secondary Sjögren's syndrome in systemic lupus erythematosus: comparison with rheumatoid arthritis and correlation with disease variables. Ann Rheum Dis (2001) 1.04
Atrophic gastritis in Sjögren's syndrome. Morphologic, biochemical, and immunologic findings. Arthritis Rheum (1985) 1.03
The comparative risk and predictors of adverse gastrointestinal events in rheumatoid arthritis and osteoarthritis: a prospective 13 year study of 2131 patients. J Rheumatol (2000) 1.03
Autoimmune hepatitis in primary Sjogren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren's syndrome. Pathol Int (2005) 1.02
Systemic rheumatoid vasculitis in the era of modern immunosuppressive therapy. Rheumatology (Oxford) (2013) 0.99
Oral Sepsis as a Cause of Disease. Br Med J (1900) 0.98
Extra-articular manifestations of rheumatoid arthritis: results of a university hospital of 526 patients in Turkey. Clin Exp Rheumatol (2006) 0.97
Otolaryngological aspects of Sjögren's syndrome. Br Med J (1971) 0.97
Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the AutoImmunity and Rituximab Registry. Arthritis Care Res (Hoboken) (2012) 0.96
Systemic AA amyloidosis: epidemiology, diagnosis, and management. Clin Epidemiol (2014) 0.95
Analysis of fecal Lactobacillus community structure in patients with early rheumatoid arthritis. Curr Microbiol (2013) 0.95
Coeliac disease in Sjögren's syndrome--a study of 111 Hungarian patients. Rheumatol Int (2003) 0.94
Presentation, survival and prognostic markers in AA amyloidosis. QJM (2000) 0.93
Biologic therapies in rheumatoid arthritis and the risk of opportunistic infections: a meta-analysis. Clin Infect Dis (2014) 0.93
Screening for amyloid in subcutaneous fat tissue of Egyptian patients with rheumatoid arthritis: clinical and laboratory characteristics. Ann Rheum Dis (2002) 0.90
Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis. Clin Rheumatol (2010) 0.90
Dysbiosis Contributes to Arthritis Development via Activation of Autoreactive T Cells in the Intestine. Arthritis Rheumatol (2016) 0.89
Rheumatoid arthritis-celiac disease relationship: joints get that gut feeling. Autoimmun Rev (2015) 0.89
Intestinal perforation and widespread arteritis in rheumatoid arthritis during treatment with cortisone. Br Med J (1959) 0.89
A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes (2015) 0.89
Abnormal hepatic biochemistries and clinical liver disease in patients with primary Sjögren's syndrome. Ann Hepatol (2007) 0.88
Clinical aspects of autoimmune pancreatitis in Sjogren's syndrome. JOP (2001) 0.88
Dysphagia and dysmotility of the pharynx and oesophagus in patients with primary Sjögren's syndrome. Scand J Rheumatol (2007) 0.87
Herpes simplex virus and the alimentary tract. Curr Gastroenterol Rep (2008) 0.87
Exocrine pancreatic function in Sjögren's syndrome. Arch Intern Med (1989) 0.87
Protein-losing gastroenteropathy associated with primary Sjögren's syndrome: a characteristic oriental variant. Rheumatol Int (2008) 0.87
Study on the safety and efficacy of tocilizumab, an anti-IL-6 receptor antibody, in patients with rheumatoid arthritis complicated with AA amyloidosis. Mod Rheumatol (2013) 0.87
Autoimmune liver disease, autoimmunity and liver transplantation. J Hepatol (2013) 0.87
Aggregatibacter actinomycetemcomitans-induced hypercitrullination links periodontal infection to autoimmunity in rheumatoid arthritis. Sci Transl Med (2016) 0.86
Types of atrophic gastritis in patients with primary Sjögren's syndrome. Ann Rheum Dis (1991) 0.86
Anti-tumour necrosis factor treatment in patients with refractory systemic vasculitis associated with rheumatoid arthritis. Ann Rheum Dis (2007) 0.86
Acute abdomen in rheumatoid arthritis due to necrotizing arteritis. Br Med J (1973) 0.86
Similarities and differences between primary and secondary Sjögren's syndrome. J Rheumatol (2010) 0.85
Autoimmune hepatitis in patients with primary Sjögren's syndrome: a series of two-hundred and two patients. Int J Clin Exp Pathol (2010) 0.85
Gastrointestinal infarction as a manifestation of rheumatoid vasculitis. Am J Gastroenterol (1998) 0.85